NDAOPHTHALMICSOLUTION/DROPS
Approved
May 2014
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20
Clinical Trials (5)
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Started Dec 2025
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Started Jun 2025
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
Started Nov 2023
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
Started Sep 2023
Travoprost Intraocular Implant in Conjunction With Cataract Surgery
Started Sep 2023
Loss of Exclusivity
LOE Date
Oct 10, 2029
43 months away
Patent Expiry
Oct 10, 2029